90 capsules containing 450 million Clostridium butyricum CBM588 per capsule.
CBM588
Food Supplement
Teoliance® CBM588® is a food supplement formulated with an exclusive probiotic strain: Clostridium butyricum CBM588®. Probiotics are defined as live microorganisms that, when administered in adequate amounts, provide health benefits to the host. They target issues related to digestive health and the intestinal microbiota, two fundamental elements for overall well-being.
Disruptions in the intestinal microbiota, known as dysbiosis, are linked to a wide range of conditions such as Irritable Bowel Syndrome (IBS), intestinal hyperpermeability, and Chronic Inflammatory Bowel Diseases (IBD). These imbalances can lead to inflammation and weakening of the intestinal barrier.
Some probiotics support digestive well-being and help restore intestinal balance by promoting the production of short-chain fatty acids (SCFAs) such as butyrate, which is naturally produced by gut bacteria through fiber fermentation. Butyrate plays a crucial role not only locally in the gut but also in reinforcing intestinal barrier integrity, reducing inflammation, and regulating interactions between the microbiota and the immune system. Probiotics help stimulate this production by restoring a favorable microbial environment for beneficial bacteria that effectively metabolize dietary fiber.
Thus, Teoliance® CBM588® is part of a proactive approach to support health and prevent imbalances that could negatively affect overall well-being.
Teoliance® CBM588® is the result of an exclusive partnership with the Japanese laboratory that owns the strain.
This partnership guarantees exclusivity on the French market, with a precise dosage of 1.35 million CFU per 3 tablets*. It features a specific and unique strain, backed by decades of rigorous scientific research. This product is developed in line with the highest quality and safety standards and integrates easily into your daily routine.
*CFU: Colony-Forming Units
Clostridium butyricum CBM588® has been widely studied, with its biological mechanism of action well-documented in the scientific literature. Many studies highlight promising potential applications in human health. However, no health claims have been approved by European legislation to date. Despite the lack of officially recognized benefits, the growing scientific interest points to promising perspectives that merit further exploration.
Clostridium butyricum CBM588® was selected based on rigorous scientific studies confirming its efficacy and unique properties. Discovered in Japan in 1933 by Dr. Miyairi, this strain has been extensively researched for decades. Clinical studies have confirmed its safe use, making CBM588® a reliable and effective solution for those looking to support digestive health.
The dosage of Clostridium butyricum CBM588® has been carefully determined to ensure both efficacy and safety. This dosage, established through rigorous clinical research, provides meaningful benefits while ensuring excellent tolerance. Teoliance® CBM588® thus guarantees an optimal effect for users.
Clostridium butyricum CBM588® is a Gram-positive, spore-forming bacterium, making it naturally resistant to stomach acid. This feature, confirmed by several studies, ensures that the strain reaches the intestinal site of action intact, where it can provide its full benefits. This characteristic reflects a commitment to quality and safety, in line with the highest international standards.
Teoliance® CBM588® is packaged in a dark glass bottle specifically designed to protect against light and moisture. This ensures the preservation of the strain’s properties throughout the product’s shelf life. The stability of the strain is guaranteed for three years, backed by extensive studies confirming the optimal conservation of its properties under standard usage conditions, ensuring consistent safety and efficacy until the expiration date.
The “Novel Food” status, as defined by European regulations, applies to foods or ingredients not widely consumed in the EU before May 15, 1997. To receive this designation, a product must undergo rigorous safety evaluation by the European Food Safety Authority (EFSA), which includes in-depth analysis of its composition, mechanism of action, safety, and absence of health risks.
Clostridium butyricum CBM588® has been granted “Novel Food” status thanks to its comprehensive scientific dossier demonstrating its non-pathogenic nature and safety as a probiotic strain. Toxicological and clinical studies confirm its safety even at high doses, ensuring full compliance with strict European regulations.
Food supplements should not be used as a substitute for a varied and balanced diet and a healthy lifestyle.
Clostridium butyricum CBM588® – 1.35 million CFU
Lactose (milk), corn starch, Clostridium butyricum (CBM588®), bulking agent: cellulose, sucrose; anti-caking agents: magnesium salts of fatty acids, talc.
Take 1 to 3 tablets per day
Do not exceed the recommended daily dose
Keep out of reach of young children
Store in a cool, dry, and dark place (< 4°C)
Consult a healthcare professional before use in children, pregnant, or breastfeeding women
Seek medical advice if taking medication
Not intended for prolonged use without professional advice
90 tablets
THERASCIENCE Luxembourg
21 RUE GLESSENER
L-1631 LUXEMBOURG
